Blood test for ovarian cancer misses some Black and Native American patients, study finds
A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study finds.
A common blood test may miss ovarian cancer in some Black and Native American patients, delaying their treatment, a new study finds. It’s the latest example of medical tests that contribute to health care disparities.
Researchers have been working to uncover these kinds of biases in medicine. Recently, the Trump administration’s crackdown on diversity, equity and inclusion has jeopardized such research as universities react to political pressure and federal agencies comb through grants looking for projects that violate the president’s orders.
